Pamela Smith
Pediatric Endocrinology · Phoenix, AZNPI 1518306448
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,920 of the $26,406 with a category attached, or 67.9%. Biomarin Pharmaceutical Inc. accounts for 74.5% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2022 at $6,524 and has fallen 69.4% since, to $1,994 in 2025. Among pediatric endocrinology clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $296.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$20K
- Ultragenyx Pharmaceutical Inc.$6K
- Pfizer$197
- AbbVie$155
- Abbott$106
- Tolmar Pharmaceuticals, Inc.$56
- plus $361 from 12 others
Across 2 payments — averaging $12,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$24K
What the payments were for
- Consulting fees$5,79322%
- Speaking & faculty fees$17,92068%
- Travel & lodging$4962%
- Food & beverage$1,5016%
- Education$6973%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 35 | $19,684 |
| Ultragenyx Pharmaceutical Inc. | 5 | $5,848 |
| Pfizer | 11 | $197 |
| AbbVie | 9 | $155 |
| Abbott | 7 | $106 |
| Tolmar Pharmaceuticals, Inc. | 3 | $56 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Insulet Corporation | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 2 | $36 |
| Rhythm Pharmaceuticals, Inc. | 2 | $35 |
| Kyowa Kirin, Inc. | 1 | $31 |
| Ascendis Pharma Endocrinology Inc | 1 | $29 |
| Novo Nordisk | 2 | $29 |
| Medtronic | 1 | $27 |
| Lilly USA, LLC | 2 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Companion Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VOXZOGO$3,938
- VOXZOGO 1.2mg$2,946
- Cryvista$2,600
How this compares
$26,406 in reported general payments places this provider in the 95th percentile of 35 pediatric endocrinology providers in Arizona.
Other pediatric endocrinology in Phoenix
- Eileen Baez IrizarryPhoenix$53K
- Chirag KapadiaPhoenix$13K
- Grazyna Piekos-SobczakPhoenix$12K
- Rola SaadPhoenix$10K
- Micah OlsonPhoenix$9K
- Rochelle WilsonPhoenix$4K
- Amanda CamposPhoenix$3K
- Mahmoud KabbaniPhoenix$3K
- Melissa ChambersPhoenix$3K
- Dorothee NewbernPhoenix$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.